• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1 群特异性抗原前体通过两条途径进行加工:对细胞毒性的影响。

The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicity.

作者信息

Kaplan A H, Swanstrom R

机构信息

Department of Medicine, University of North Carolina, Chapel Hill 27599-7295.

出版信息

Biomed Biochim Acta. 1991;50(4-6):647-53.

PMID:1801737
Abstract

All retroviruses studied thus far contain proteases which process viral precursors to liberate the structural and enzymatic proteins of the viral capsid. We have examined the processing of the Gag precursor of HIV-1 which is composed of the viral structural proteins. Our results indicate that Gag is processed via two pathways: an expected membrane-associated pathway which gives rise to virions and a cytoplasmic pathway in which processed viral proteins accumulate in the cytoplasm. The presence of an active protease in the cytoplasm of infected cells is a potential source of toxicity. A comparison of the extent of cytoplasmic processing in lytically infected cells compared with that in cells which are not killed by the virus demonstrates a close correlation between cytoplasmic processing and cell killing.

摘要

迄今为止所研究的所有逆转录病毒都含有蛋白酶,这些蛋白酶加工病毒前体以释放病毒衣壳的结构蛋白和酶蛋白。我们已经研究了HIV-1的Gag前体的加工过程,该前体由病毒结构蛋白组成。我们的结果表明,Gag通过两条途径进行加工:一条是预期的与膜相关的途径,可产生病毒粒子;另一条是细胞质途径,加工后的病毒蛋白在细胞质中积累。感染细胞的细胞质中存在活性蛋白酶是潜在的毒性来源。与未被病毒杀死的细胞相比,对裂解感染细胞中细胞质加工程度的比较表明,细胞质加工与细胞死亡之间存在密切关联。

相似文献

1
The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicity.HIV-1 群特异性抗原前体通过两条途径进行加工:对细胞毒性的影响。
Biomed Biochim Acta. 1991;50(4-6):647-53.
2
Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.有效的人类免疫缺陷病毒多聚蛋白加工和颗粒成熟需要pol的广泛区域。
Virology. 1996 May 1;219(1):29-36. doi: 10.1006/viro.1996.0219.
3
Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.人类免疫缺陷病毒1型感染的母婴中,HIV-1蛋白酶、Gag p7和p6以及gag/pol多蛋白内蛋白酶切割位点的自然变异:无蛋白酶抑制剂情况下的氨基酸替代
Virology. 1996 May 15;219(2):407-16. doi: 10.1006/viro.1996.0266.
4
Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.人类免疫缺陷病毒1型(HIV-1)Gag p7(NC)中天然存在的氨基酸多态性以及C切割位点会影响HIV-1蛋白酶对Gag-Pol的加工。
Virology. 2002 Jan 5;292(1):137-49. doi: 10.1006/viro.2001.1184.
5
Regulation of intracellular human immunodeficiency virus type-1 protease activity.细胞内人类免疫缺陷病毒1型蛋白酶活性的调节
Virology. 1998 Apr 25;244(1):87-96. doi: 10.1006/viro.1998.9083.
6
Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.1型人类免疫缺陷病毒的Gag蛋白在两个细胞区室中进行加工。
Proc Natl Acad Sci U S A. 1991 May 15;88(10):4528-32. doi: 10.1073/pnas.88.10.4528.
7
Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.蛋白酶结构域下游存在截短的1型人类免疫缺陷病毒Pr160 gag-pol突变体的特征分析
Virology. 2004 Nov 10;329(1):180-8. doi: 10.1016/j.virol.2004.08.010.
8
Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions.
J Med Primatol. 1990;19(3-4):411-9.
9
Characterization of clones of HIV-1 infected HuT 78 cells defective in gag gene processing and of SIV clones producing large amounts of envelope glycoprotein.
J Med Primatol. 1990;19(3-4):351-66.
10
In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes.在急性感染的培养人T淋巴细胞中对来自1型人类免疫缺陷病毒(HIV)的Pr160gag-pol进行体内加工。
Virology. 1995 Dec 20;214(2):624-7. doi: 10.1006/viro.1995.0074.

引用本文的文献

1
Engineered packaging cell line for the enhanced production of baboon-enveloped retroviral vectors.用于增强狒包膜逆转录病毒载体生产的工程包装细胞系。
Mol Ther Nucleic Acids. 2024 Nov 13;35(4):102389. doi: 10.1016/j.omtn.2024.102389. eCollection 2024 Dec 10.
2
Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells.利用重新利用的药物增加前半胱天冬酶8的表达,以诱导离体患者细胞中受HIV感染的细胞死亡。
PLoS One. 2017 Jun 19;12(6):e0179327. doi: 10.1371/journal.pone.0179327. eCollection 2017.
3
Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size.
启动、冲击与清除:在HIV重新激活前用BCL-2拮抗剂预处理HIV患者的CD4 T细胞可减小HIV储存库规模。
J Virol. 2016 Mar 28;90(8):4032-4048. doi: 10.1128/JVI.03179-15. Print 2016 Apr.
4
Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors.生成一个稳定的包装细胞系,产生高滴度 PPT 缺失整合缺陷慢病毒载体。
Mol Ther Methods Clin Dev. 2015 Jul 22;2:15025. doi: 10.1038/mtm.2015.25. eCollection 2015.
5
RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.RD2-MolPack-Chim3,一种用于抗HIV基因治疗的慢病毒载体稳定生产的包装细胞系。
Hum Gene Ther Methods. 2013 Aug;24(4):228-40. doi: 10.1089/hgtb.2012.190. Epub 2013 Aug 3.
6
The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak.HIV-1 特异性蛋白 Casp8p41 通过 Bax/Bak 诱导感染细胞死亡。
J Virol. 2011 Aug;85(16):7965-75. doi: 10.1128/JVI.02515-10. Epub 2011 Jun 8.
7
Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo.1型人类免疫缺陷病毒蛋白酶在体内切割前半胱天冬酶8。
J Virol. 2007 Jul;81(13):6947-56. doi: 10.1128/JVI.02798-06. Epub 2007 Apr 18.
8
Phosphorylation and proteolytic cleavage of gag proteins in budded simian immunodeficiency virus.出芽的猴免疫缺陷病毒中gag蛋白的磷酸化和蛋白水解切割
J Virol. 2005 Feb;79(4):2484-92. doi: 10.1128/JVI.79.4.2484-2492.2005.
9
Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1.致力于开发一种基于病毒-细胞的检测方法,用于发现抗1型人类免疫缺陷病毒的新型化合物。
Antimicrob Agents Chemother. 2003 Feb;47(2):501-8. doi: 10.1128/AAC.47.2.501-508.2003.
10
Engraftment of NOD/SCID mice with human CD34(+) cells transduced by concentrated oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein.用人CD34(+)细胞移植NOD/SCID小鼠,这些细胞由用猫内源性逆转录病毒(RD114)包膜蛋白假型化的浓缩嗜肝性逆转录病毒载体颗粒转导。
J Virol. 2001 Oct;75(20):9995-9. doi: 10.1128/JVI.75.20.9995-9999.2001.